A. Mackenzie et al., INCIDENCE AND PATHOGENICITY OF ARCANOBACTERIUM-HAEMOLYTICUM DURING A 2-YEAR STUDY IN OTTAWA, Clinical infectious diseases, 21(1), 1995, pp. 177-181
Arcanobacterium haemolyticum has been described as a rare cause of sys
temic invasive disease and is occasionally isolated from throat swabs.
We describe a 2-year study of the incidence and clinical features of
A. haemolyticus infection in a pediatric and adolescent population. A
total of 11,620 throat swabs were examined for A. haemolyticum with us
e of a locally developed selective medium. Controls (2,241) were healt
hy students who were recruited from a separate study. A. haemolyticum
was isolated from 42 patients, with the maximum incidence in the 15 to
18-year-old age group; in this subset the incidence was 2.5%. There w
ere no isolates of A. haemolyticum found in the healthy controls, and
the difference in incidence between patients and controls in the 15 to
18-year-old age group was highly significant (P <.01). Approximately
half of the patients infected with A. haemolyticum had a rash. In 5 pa
tients, A. haemolyticum was associated with a positive monospot test.
The organism was highly susceptible to erythromycin and less susceptib
le to penicillin. The evidence from this study suggests that A. haemol
yticum may be a pathogen with maximum incidence in the 15 to 18-year-o
ld age group.